PRESTIGE CONSMR (PBH)
(Delayed Data from NYSE)
$74.04 USD
-0.16 (-0.22%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $74.01 -0.03 (-0.04%) 5:02 PM ET
4-Sell of 5 4
B Value C Growth A Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
PBH 74.04 -0.16(-0.22%)
Will PBH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PBH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PBH
AdaptHealth Corp. (AHCO) Lags Q2 Earnings and Revenue Estimates
Why Prestige Consumer Healthcare (PBH) is a Top Value Stock for the Long-Term
PBH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Thermo Fisher Stock Hurt by Macroeconomic Woes, Tough Competition
Here's Why You Should Retain AMED Stock in Your Portfolio for Now
Here's Why You Should Retain PODD Stock in Your Portfolio Now
Other News for PBH
Insights Ahead: Prestige Consumer's Quarterly Earnings
PointsBet Rejects Betr’s Offer in Favor of MIXI’s Cash Proposal
Prestige Consumer Healthcare Inc (PBH) Announces Upcoming Fiscal 2026 Q1 Earnings Release | PBH ...
PointsBet Director’s Interest Update: Equity Changes Announced
What Does the Market Think About Prestige Consumer?